Applied Genetic Technologies
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Applied Genetic Technologies generated cash of -$65,748,000, which is less than the previous year. Cash used in financing activities reached the amount of $7,076,000 last year. Net change in cash is therefore -$58,686,000.
Cash Flow
| 2013 | -2.77M | -14.48M | 25.37M |
|---|---|---|---|
| 2014 | -11.92M | -50.82M | 62.48M |
| 2015 | -19.48M | 17.89M | 32.15M |
| 2016 | 70.99M | -100.80M | 19.49M |
| 2017 | -31.00M | 32.81M | 28K |
| 2018 | -32.52M | 33.01M | -136K |
| 2019 | -23.45M | 19.02M | 68K |
| 2020 | -41.62M | 8.39M | 44.98M |
| 2021 | -51.17M | 38.14M | 79.61M |
| 2022 | -65.74M | -14K | 7.07M |
AGTC Cash Flow Statement (2013 – 2022)
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 105.05M | 38.46M | 26.70M | 31.06M | 30.70M | 28.86M | 39.18M | 8.62M | 8.89M | 774K |
Operating activities | ||||||||||
Net income | -68.94M | -57.82M | -45.89M | -2.00M | -21.3M | 407K | -1.38M | -24.31M | -15.90M | -4.99M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 1.51M | 1.46M | 1.33M | 1.27M | 1.17M | 912K | 567K | 376K | 334K | 285K |
Stock-based compensation expense | 3.45M | 2.67M | 2.99M | 4.02M | 5.19M | 5.60M | 5.64M | 2.82M | 825K | 25K |
| Deferred income tax benefit | 3.45M | 2.67M | 2.99M | 4.02M | 5.19M | 5.60M | 5.64M | 2.82M | 825K | 25K |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 0 | 0 | 13K | 186K | -36K | 780K | 409K | -876K | -343K | 41K |
Inventories | 0 | 0 | 1.84M | 2.23M | 423K | -592K | 1.94M | -57.20M | -174K | -402K |
Accounts payable | 991K | 497K | 83K | 327K | -53K | -333K | 140K | 228K | 156K | 674K |
Cash generated by operating activities | -65.74M | -51.17M | -41.62M | -23.45M | -32.52M | -31.00M | 70.99M | -19.48M | -11.92M | -2.77M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | -20.99M | -58.90M | -74.78M | -67.08M | -67.54M | -208.18M | -102.86M | -79.95M | -14M |
Investments In Property Plant And Equipment | -2.01M | -1.86M | -1.19M | -311K | -803K | -891K | -2.59M | -323K | -376K | -531K |
Acquisitions Net | 0 | 404K | -4M | 148K | 141K | -2M | 121K | 98K | 218K | 0 |
Cash generated by investing activities | -14K | 38.14M | 8.39M | 19.02M | 33.01M | 32.81M | -100.80M | 17.89M | -50.82M | -14.48M |
Financing activities | ||||||||||
Common Stock Issued | 9.20M | 69.26M | 34.81M | 36K | 49K | 0 | 19.21M | 32.00M | 51.60M | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | -48K | -45K | 0 | -43K | 0 | 0 | 0 | -1K | -857K |
Cash used in financing activities | 7.07M | 79.61M | 44.98M | 68K | -136K | 28K | 19.49M | 32.15M | 62.48M | 25.37M |
Net Change In Cash | -58.68M | 66.58M | 11.76M | -4.36M | 359K | 1.83M | -10.31M | 30.56M | -270K | 8.11M |
Cash at end of period | 46.36M | 105.05M | 38.46M | 26.70M | 31.06M | 30.70M | 28.86M | 39.18M | 8.62M | 8.89M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |